prikaz prve stranice dokumenta MAGNETSKA REZONANCIJA KAO METODA ZA PROCJENU REZIDUALNOG KARCINOMA DOJKE NAKON PROVEDENE NEOADJUVANTNE TERAPIJE
  Download
PDF 658.56 KB
master's thesis
MAGNETSKA REZONANCIJA KAO METODA ZA PROCJENU REZIDUALNOG KARCINOMA DOJKE NAKON PROVEDENE NEOADJUVANTNE TERAPIJE
2020. urn:nbn:hr:184:030375
Panić, Tanja
University of Rijeka
Faculty of Health Studies
Department of Midwifery

Cite this document

Panić, T. (2020). MAGNETSKA REZONANCIJA KAO METODA ZA PROCJENU REZIDUALNOG KARCINOMA DOJKE NAKON PROVEDENE NEOADJUVANTNE TERAPIJE (Master's thesis). Rijeka: University of Rijeka, Faculty of Health Studies. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:030375

Panić, Tanja. "MAGNETSKA REZONANCIJA KAO METODA ZA PROCJENU REZIDUALNOG KARCINOMA DOJKE NAKON PROVEDENE NEOADJUVANTNE TERAPIJE." Master's thesis, University of Rijeka, Faculty of Health Studies, 2020. https://urn.nsk.hr/urn:nbn:hr:184:030375

Panić, Tanja. "MAGNETSKA REZONANCIJA KAO METODA ZA PROCJENU REZIDUALNOG KARCINOMA DOJKE NAKON PROVEDENE NEOADJUVANTNE TERAPIJE." Master's thesis, University of Rijeka, Faculty of Health Studies, 2020. https://urn.nsk.hr/urn:nbn:hr:184:030375

Panić, T. (2020). 'MAGNETSKA REZONANCIJA KAO METODA ZA PROCJENU REZIDUALNOG KARCINOMA DOJKE NAKON PROVEDENE NEOADJUVANTNE TERAPIJE', Master's thesis, University of Rijeka, Faculty of Health Studies, accessed 11 July 2024, https://urn.nsk.hr/urn:nbn:hr:184:030375

Panić T. MAGNETSKA REZONANCIJA KAO METODA ZA PROCJENU REZIDUALNOG KARCINOMA DOJKE NAKON PROVEDENE NEOADJUVANTNE TERAPIJE [Master's thesis]. Rijeka: University of Rijeka, Faculty of Health Studies; 2020 [cited 2024 July 11] Available at: https://urn.nsk.hr/urn:nbn:hr:184:030375

T. Panić, "MAGNETSKA REZONANCIJA KAO METODA ZA PROCJENU REZIDUALNOG KARCINOMA DOJKE NAKON PROVEDENE NEOADJUVANTNE TERAPIJE", Master's thesis, University of Rijeka, Faculty of Health Studies, Rijeka, 2020. Available at: https://urn.nsk.hr/urn:nbn:hr:184:030375

Please login to the repository to save this object to your list.
Metadata
TitleMAGNETSKA REZONANCIJA KAO METODA ZA PROCJENU REZIDUALNOG KARCINOMA DOJKE NAKON PROVEDENE NEOADJUVANTNE TERAPIJE
Title (english)MAGNETIC RESONANCE IMAGING AS A METHOD OF RESIDUAL BREAST CANCER ASSESSMENT AFTER THE NEOADJUVANT THERAPY COMPLETION
AuthorTanja Panić
MentorDamir Grebić (mentor)
Committee memberElvira Mustać (predsjednik povjerenstva)
Committee memberTanja Ćelić (član povjerenstva)
Committee memberDamir Grebić (član povjerenstva)
GranterUniversity of Rijeka
Faculty of Health Studies
(Department of Midwifery)
Rijeka
Defense date and country2020-07-27, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Surgery
Abstract
Karcinom dojke najčešća je zloćudna bolest u razvijenim zemljama svijeta. Tijekom terapije karcinoma dojke ključno je praćenje razvoja tumorskog procesa. Ovim radom utvrđeno je kako je kod 50 ispitanih pacijentica s karcinomom dojke podvrgnutih neoadjuvantnoj kemoterapiji utvrđena značajna redukcija veličine tumorskog procesa. Usporedbom magnetske rezonancije i patohistološke dijagnostike koja se smatra „zlatnim standardom“ dijagnostike nisu utvrđene statistički značajne razlike (p = 0.552), uz r koeficijent korelacije 0.64 (p < 0.001) između tih dvaju statističkih metoda. Magnetska rezonancija u prosjeku je precjenjivala veličinu tumorskog procesa u odnosu na PHD, ali pokazala se dobrom metodom za procjenu veličine tumorskog procesa dojke kod pacijentica koje su podvrgnute neoadjuvantnoj kemoterapiji. Zaključak ovog istraživanja je kako nema proporcionalnog i konstatnog odstupanja u mjerenjima, te se metode mogu smatrati podudarnima.
Abstract (english)
Breast cancer is the most often malign disease in the developed world countries. During the breast cancer therapy the quality monitoring of the tumor process is crucial. This paper shows that with 50 patients subjected to the neoadjuvant chemotherapy there was significant reduction in size of the tumor process. With comparison of the magnetic resonance imaging and histopathological diagnostic which is considered as a “golden standard” of tumor diagnostics there was no significant statistical difference (p = 0.552), with r correlation coefficient. 0.64 (p < 0.001) between these two diagnostical methods. MR in average underestimated the size of the tumor process in relation to histopathological diagnostics but proved to be a good method to estimate the size of the breast tumor size with the patients subjected to the neoadjuvant chemotherapy. The conclusion of this research is that there is no proportional and constant deviation in the results, and two analyzed diagnostical methods can be considered identical.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:184:030375
Study programmeTitle: Graduate university study of Nursing: Healthcare Management (Biomedicine and Healthcare; clinical medical sciences)
Study programme type: university
Study level: graduate
Academic / professional title: magistar/magistra sestrinstva (magistar/magistra sestrinstva)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2020-12-07 08:53:46